Impel Pharmaceuticals Inc (IMPL) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Impel Pharmaceuticals Inc   (NASDAQ: IMPL)


Impel Pharmaceuticals Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Impel Pharmaceuticals Inc 's ROA in the third quarter of 2023?
Impel Pharmaceuticals Inc recorded a cumulative net loss of $-74 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -133.84%.

However, within the Healthcare sector 956 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 5014, from total ROA ranking in the second quarter of 2023 at 5093.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -68.75 % -64.6 % -58.25 % -11.48 % -14.35 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -74 -92 -109 -106 -108
Return On Assets (TTM) -133.84 % -124.77 % -118.32 % -93.47 % -92.68 %
IMPL's Total Ranking # 5014 # 5093 # 5229 # 5906 # 5224
Total Assets (TTM) in million 33 42 61 87 104
Seq. Total Assets Change -22.3 % -31.36 % -29.66 % -16.7 % -11.97 %
Seq. Net Income Change - - - - -

IMPL's 5 Years Annual ROA >> Back to IMPL Management Effectiveness >> Compare IMPL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 459
Sector # 957
Overall # 4923

Return On Assets Statistics
High Average Low
-83.62 %
-102.2 %
-127.43 %
(Jun 30 2022)   (Sep 30 2023)





Financial Statements
Impel Pharmaceuticals Inc 's Assets $ 33 million IMPL's Balance sheet
Impel Pharmaceuticals Inc 's Income $ -14 million Quarterly IMPL's Income Statement
IMPL's Income by Division See IMPL's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
FY
Y / Y Total Assets Change -11.48 % - - - -
Total Assets in million 87 98 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -106 -77 0 0 0
Annual Return On Assets -122.66 % -78.17 % - - -

IMPL's 5 Years Annual ROA >> Back to IMPL Management Effectiveness >> Compare IMPL ROA to its Competitors



More Return On Assets Ratios
IMPL's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMPL's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMPL's Competitors
Subscribers only: Roa for Impel Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for IMPL's Customers

You may also want to know
IMPL's Roi IMPL's Inventory Turnover Ratio IMPL's Growth Rates IMPL's Dividend Comparisons
IMPL's Profitability Ratios IMPL's Asset Turnover Ratio IMPL's Dividend Growth
IMPL's Roe IMPL's Valuation Ratios IMPL's Financial Strength Ratios IMPL's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:07+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.